Safety Study of Dabigatran in CADASIL

NCT01361763 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

CADASIL

Interventions

DRUG: Dabigatran
DRUG: Antiplatelets

Sponsor

S. Andrea Hospital